Moderna MRNA
NASDAQ MRNA
$218.00 -18.50 (-7.82%)
As of: Oct 16, 2026 · 3:59 PM EDT

Moderna (MRNA) Gross Profit (2020 - 2026)

Updated

Moderna's Gross Profit was $52 million in Q2 2026, up 126.1% from $23 million a year earlier.

Analysis

Moderna (MRNA) Gross Profit (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, Moderna's Gross Profit was $521 million through Jun 30, 2026, down 67.8% year-over-year; for FY2025, it came in at $1.08 billion, down 39.3% from FY2024.

  • Gross Profit has now declined for four consecutive years, though with a five-year compound annual growth rate of 6.2% (FY2020 to FY2025).
  • In earlier years, Gross Profit was $1.77 billion in FY2024 (-17.8%), $2.16 billion in FY2023 (-84.4%), $13.85 billion in FY2022 (-12.7%) and $15.85 billion in FY2021.
  • Quarterly Gross Profit has moved between -$566 million (Q1 2026) and $6.26 billion (Q4 2021) over five years.
  • Compared with a year earlier, Gross Profit was higher in 1 of the last six quarters, with an average decline of 26.4%.
  • The best year-over-year quarter for Gross Profit over five years was Q1 2022 (growth of 189.5%); the worst was Q1 2024 (a decline of 93.4%).
  • Per Business Quant data, MRNA's Gross Profit in the three quarters before Q2 2026 was -$566 million (Q1 2026), $226 million (Q4 2025) and $809 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
API Access

Moderna Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=MRNA&period=max&api_key=YOUR_API_KEY